University of Toledo Medical Center

Toledo, Ohio 43623

3 studies enrolling now · 58 studies all time

What they study most

Advanced Gastrointestinal Stromal Tumors, Anemia, Artery Disease, Peripheral, Atherosclerosis of Native Arteries of the Extremities, Atrial Fibrillation (AF), Burnout, Professional, COVID-19, Cardiac Surgery, Cardiopulmonary Bypass, Carotid Artery Disease, Cholangiocarcinoma, Chronic Pain

Studies at this site

• A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease — Recruiting now
• Patient Retrospective Outcomes (PRO) — Recruiting now
• RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain — Recruiting now
• (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors — Recruiting now
• A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) — Recruiting now
• Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study — Recruiting now
• DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma — Recruiting now
• A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes — Running, not enrolling
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) — Completed
• IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC — Completed
• A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity — Running, not enrolling
• A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State — Running, not enrolling
• An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies — Stopped early
• Hybrid Coronary Revascularization Trial — Completed
• Safety and Efficacy of the SurVeil™ Drug-Coated Balloon — Completed
• Social Determinants of Health Screening and Interventions — Completed
• Influence of Custom Orthosis Post Carpometacarpal (CMC) Arthroplasty — Completed
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• The Impact of Diabetes on REvascularization — Completed
• A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc) — Stopped early
• Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies — Status unconfirmed
• Myocardial Ischemia and Transfusion — Completed
• Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome — Withdrawn before enrolling
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation Follow-on Safety "Roll-over" Study (Rollover) — Stopped early
• Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET) — Completed
• Study of Sargramostim in Patients With COVID-19 — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent — Completed
• Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes — Completed
• Zilver® PTX® V Clinical Study — Completed
• Catheter-directed Thrombolysis Compared to Anticoagulation Alone for Acute Primary Iliofemoral Deep Venous Thrombosis — Withdrawn before enrolling
• An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) — Completed
• Effectiveness of the Precision Spinal Cord Stimulator System at Sub-Perception Amplitude — Completed
• ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients — Stopped early
• Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy — Stopped early
• Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer — Stopped early
• Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements — Stopped early
• Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction — Stopped early
• Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer — Stopped early
• Beraprost-314d Added-on to Tyvaso® (BEAT) — Completed
• Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers — Stopped early
• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. — Completed
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• T-SPOT.CMV and T-SPOT.PRT Diagnostic Assays — Completed
• Safety and Efficacy of Preoperative Antithrombin Supplementation in Patients Undergoing High-Risk Cardiopulmonary Bypass — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Effects of Spinal Cord Stimulation on Sensory Perceptions of Chronic Pain Patients — Completed
• A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke — Stopped early